Myriad Genetics Inc (MYGN)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 298,000 | 313,600 | 274,600 | 484,800 | 389,400 |
| Total current liabilities | US$ in thousands | 164,100 | 155,900 | 137,200 | 204,300 | 145,900 |
| Current ratio | 1.82 | 2.01 | 2.00 | 2.37 | 2.67 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $298,000K ÷ $164,100K
= 1.82
The current ratio of Myriad Genetics Inc has been relatively stable over the past few years, ranging from 2.67 in December 31, 2020 to 1.82 in December 31, 2024. A current ratio above 1 indicates that the company's current assets are sufficient to cover its current liabilities, suggesting strong short-term financial health and liquidity.
The slight decrease in the current ratio from 2020 to 2024 may indicate a change in the composition of current assets and liabilities, or perhaps a shift in the company's operating and financing activities. It is important for investors and stakeholders to monitor changes in the current ratio over time to assess the company's ability to meet its short-term obligations and manage working capital effectively.
Peer comparison
Dec 31, 2024